| Asset | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 | 31 Dec 2025 |
|---|---|---|---|---|---|---|
| Equity | 97.49% | 97.38% | 98.16% | 97.00% | 98.53% | 96.59% |
| Debt | 0.06% | 0.07% | 0.07% | 0.07% | 0.08% | 0.07% |
| Others (incl. cash) | 2.45% | 2.55% | 1.77% | 2.93% | 1.39% | 3.34% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 28,00,000 | 503.78 | 11.03% | -0.68%↓ |
| Divis Laboratories Ltd. | Healthcare | 4,50,000 | 300.02 | 6.57% | -0.20%↓ |
| Acutaas Chemicals Ltd. | Healthcare | 9,00,000 | 281.93 | 6.17% | 0.77%↑ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 3,00,000 | 245.3 | 5.37% | 0.07%↑ |
| Max Healthcare Institute Ltd. | Healthcare | 22,50,000 | 217.15 | 4.76% | -0.41%↓ |
| Aurobindo Pharma Ltd. | Healthcare | 12,50,000 | 178.3 | 3.90% | 0.69%↑ |
| Aster DM Healthcare Ltd. | Healthcare | 24,00,000 | 174.8 | 3.83% | -0.06%↓ |
| Laurus Labs Ltd. | Healthcare | 12,00,000 | 163.44 | 3.58% | 0.52%↑ |
| Biocon Ltd. | Healthcare | 37,50,000 | 160.74 | 3.52% | 0.40%↑ |
| Torrent Pharmaceuticals Ltd. | Healthcare | 3,60,000 | 158.79 | 3.48% | 0.00% |
| Fortis Healthcare Ltd. | Healthcare | 15,00,000 | 139.27 | 3.05% | -0.15%↓ |
| Anthem Biosciences Ltd. | Healthcare | 18,02,207 | 136.96 | 3.00% | -0.45%↓ |
| Gland Pharma Ltd. | Healthcare | 6,00,000 | 135 | 2.96% | 0.53%↑ |
| Mankind Pharma Ltd. | Healthcare | 5,60,000 | 133.03 | 2.91% | -0.42%↓ |
| Aether Industries Ltd. | Chemicals | 11,00,000 | 120.78 | 2.65% | -0.70%↓ |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 9,00,000 | 119.44 | 2.62% | 0.07%↑ |
| Sai Life Sciences Ltd. | Healthcare | 10,00,000 | 116 | 2.54% | 0.07%↑ |
| Sudeep Pharma Ltd. | Healthcare | 13,60,000 | 100.93 | 2.21% | -0.02%↓ |
| Alkem Laboratories Ltd. | Healthcare | 1,75,000 | 96.22 | 2.11% | -0.39%↓ |
| Lupin Ltd. | Healthcare | 4,00,000 | 90.71 | 1.99% | -1.85%↓ |
| Sector | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 | 31 Dec 2025 |
|---|---|---|---|---|---|---|
| Healthcare | 94.84% | 94.03% | 94.60% | 93.71% | 94.86% | 93.57% |
| Chemicals | 2.65% | 3.35% | 3.56% | 3.29% | 3.67% | 3.02% |
23.0 / 100
Weighted average Value score is 23.0. This indicates that portfolio is relatively overvalued using composite of value measures.
77.1 / 100
Weighted average Price Momentum score is 77.1. This indicates that portfolio has high momentum using composite of momentum measures.
86.2 / 100
Weighted average Quality score is 86.2. This indicates that portfolio has high quality using composite of quality measures.
71.3 / 100
Weighted average QVM score is 71.3. This indicates that portfolio has average QVM score and hence a neutral stance is warranted.
